CHEK2 and gastric cancer: These findings position CHK1 as a constitutively present yet contextually regulated component of the DDR machinery in gastric cancer, and highlight the necessity of its proper activation, alongside TP53 and CHK2, for effective cellular response to genotoxic stress [114].